Novavax COVID-19 vaccine to be considered by FDA panel as 4th in US - USA TODAY

A more traditional vaccine than some of the others, Novavax's offering might encourage some COVID-19 vaccine holdouts to get the shot, experts said.

A federal vaccine advisory committee meets Tuesday to decide whether adult Americans could soon get a fourth COVID-19 vaccine option.  Development of the vaccine, from Novavax, a Gaithersburg, Maryl… [+7581 chars]

full article...